Evidence map›Paper›PMID 42590886›Full record

ReviewActa physiologica (Oxford, England)2026

The Neurovascular Niche: A Gathering Venue for Neuroinflammation and Remyelination in Multiple Sclerosis.

Ilias Kazanis, Maria Elena Silva, Alerie G de la Fuente, Fernando de Castro, Francisco J Rivera

Abstract readReview
In one paragraph

Review in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ilias KazanisCentre for Resilience, Ageing Biology and Age-related Diseases Group, School of Life Sciences, University of Westminster, London, UK.ORCID https://orcid.org/0000-0003-1035-0584
Maria Elena SilvaTranslational Regenerative Neurobiology Group (TReN), Department of Molecular and Integrative Biosciences (MIBS), Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0000-0001-6236-7180
Alerie G de la FuenteInstituto de Neurosciencias CSIC-UMH, San Juan de Alicante, Alicante, Spain.ORCID https://orcid.org/0000-0001-8366-4969
Fernando de CastroMyelin Dynamics & Repair Lab, Centro de Neurociencias Cajal/Instituto Cajal-CSIC, Alcalá de Henares (Madrid), Spain.ORCID https://orcid.org/0000-0002-7018-8032
Francisco J RiveraTranslational Regenerative Neurobiology Group (TReN), Department of Molecular and Integrative Biosciences (MIBS), Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland.ORCID https://orcid.org/0000-0001-7895-6318

Funding

Agencia Estatal de InvestigaciónAgencia Nacional de Investigación y Desarrollo FONDECYT-Regular 1201706Asociación Europea contra la Leucodistrofia-ELA -Spain- and Fundación Hesperia -Spain-EDRF/EU 050601240019European Union to Fernando de Castro PID2024-161979OB-I00Finnish Multiple Sclerosis FoundationHellenic Foundation for Research and Innovation HFRI-FM17-3395Ministerio de Ciencia e Innovación PID2022-143110OB-I00Ministerio de Ciencia Inovación y Universidades, Agencia Estatal de Investigación RYC2023-045776-IResearch Council of Finland Academy-Project 370013Sigrid Juséliuksen Säätiö
6 · The paper itself

Abstract

In the central nervous system (CNS), the tissue microenvironment is continuously monitored and regulated to secure the unobstructed function of neurons and of their networks. This is a key function of the neurovascular niche (NVN), which is the interface between the cells of the nervous tissue and the cells and the content of blood vessels. It is enabled by the Blood-Brain Barrier, a structure formed by endothelial and perivascular cells, extracellular matrix, and astrocytes, and is manifested by the limited surveillance of the CNS from blood-derived cells. Multiple sclerosis (MS) is a devastating degenerative disorder, in which the myelin sheaths that enwrap neuronal axons are destroyed, leading, over time, to neurological symptoms. MS has a strong immunological component which is targeted in most of the current disease-modifying treatments. Nevertheless, regenerative interventions aiming at enhancing and restoring the endogenous remyelination potential of the CNS, driven by the abundant Oligodendrocyte Progenitor Cells (OPCs), have not been successfully developed so far. Here, we will review key information on the structure of the NVN, and we will summarize the evidence on the role of inflammation in the emergence and the progress of MS, with a focus on the active response of OPCs. We will also present recent experimental evidence on the role of less investigated cellular elements of the NVN, such as pericytes and platelets, in the regulation of OPCs. Finally, we will discuss current and future treatments for MS.

Indexed as

Central Nervous SystemMultiple SclerosisNeuroinflammatory DiseasesRemyelinationAnimalsBlood-Brain BarrierHumansInflammationMyelin Sheathblood elementsCNS stem/progenitor cellsCNS vascular and perivascular cellsimmune cellsMultiple sclerosisneuroinflammationremyelination

Identifiers

PMID42590886
PMCPMC13469792

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.